WhatsApp, WeChat & Telegram : +8801886229488, Email : aiopharma@outlook.com

Ponatinix (Ponatinib) 15/45 mg

Generic Name: Ponatinib

Manufacturer: Beacon pharma

Tablet: 30’s Pot / 60’s Pot

Originator: Iclusig by Ariad Pharma

Contact For Order:

WhatsApp & WeChat: +8801886229488

Email: aiopharma@outlook.com

WeChat QR CodeAio Pharma QR code

Categories: ,

Ponatinib (Ponatinib) treats blood cancer, with an overall survival rate of 80.5%. Once daily convenient dose. ponatinix manufactured by beacon pharma.

FAQ about Ponatinix (Ponatinib)

Q: What is Ponatinix (Ponatinib) uses for?

It is a treatment for some types of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL).
Adjustable testosteron kaufen online Back Extension / Hyperextension bench, Panatta in Tessin acheter – Fitness and Service | tutti.ch mast test cycle fitness anal babe multiniche clips
Q: What generation is ponatinib?

Ponatinib: A Third-Generation Inhibitor for the Treatment of CML.

Q: Is ponatinib a chemotherapy drug?

Ponatinib is not a chemotherapy drug but one of many “targeted therapies.” About 100 years of research dedicated to understanding the differences between cancer cells and normal cells has resulted in targeted therapy.

Q: How effective is ponatinib?

The ponatinib initial daily dose was 45 mg in 60% of patients, 30 mg in 38% and 15 mg in 2% of patients. After a median time of 12 months, 85% of patients achieved a better molecular response compared with the baseline. Among them, 10 (40%) patients achieved a deep molecular response. We observed no AOEs (Table 2).


Product Description:

Ponatinix (Ponatinib), is an oral drug under the generic of Ponatinib, for the first-line therapy of the people affected with chronic myelogenous leukemia.

is a highly potential and multi-targeted third-generation Bcr-Abl tyrosine-kinase inhibitor (TKI). which is indicated for adult patients with chronic phase, accelerated phase, or blast phase chronic myeloid leukemia (CML) or Ph+ALL for those who have no other TKI therapy.

It is also indicated for adult patients with T315I-positive CML (chronic phase, accelerated phase, or blast phase) or T315I-positive Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL).

Product Features:

Product Name : Ponatinix
Generic Name : Ponatinib
Formulation : Tablet
Available Pack Size : 60’s pot
Available Strength : 15 mg
Registrations : Export Only


There are no reviews yet.

Be the first to review “Ponatinix (Ponatinib) 15/45 mg”

Your email address will not be published. Required fields are marked *